Suchergebnisse - "Carlo-Stella, Carmelo"

PubPharm (14)

1

A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Kahl, B. | Hamadani, M. | Radford, J. | +12

2

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

enthalten in: Blood | 2017

von Merryman, R. | Kim, H. | Zinzani, P. | +28

3

Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2013

von Devizzi, L. | Guidetti, A. | Seregni, E. | +14

4

Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathways

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2012

von Tassi, E. | Zanon, M. | Vegetti, C. | +11

5

Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia

enthalten in: Cancer | 2011

von Guidetti, A. | Carlo-Stella, C. | Ruella, M. | +12

6

High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion : an outpatient preparative regimen for autologous hematopoietic cell transplantation

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2008

von Devizzi, L. | Guidetti, A. | Tarella, C. | +8

CommentIn: J Clin Oncol. 2008 Nov 10;26(32):5147-50. - PMID 18854559

7

The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells

enthalten in: Haematologica | 2008

von Zappasodi, R. | Di Nicola, M. | Carlo-Stella, C. | +6

CommentIn: Haematologica. 2008 Oct;93(10):1452-6. - PMID 18827263

8

IFN-gamma enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1D09C3

enthalten in: Cancer research | 2007

von Carlo-Stella, C. | Guidetti, A. | Di Nicola, M. | +11

9

CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice

enthalten in: Experimental hematology | 2006

von Carlo-Stella, C. | Guidetti, A. | Di Nicola, M. | +10

10

The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice

enthalten in: Cancer research | 2006

von Carlo-Stella, C. | Di Nicola, M. | Turco, M. | +11